{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:31:08Z","timestamp":1790303468026,"version":"4.1.0"},"reference-count":158,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Neurobiology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.conb.2020.02.001","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T12:40:55Z","timestamp":1583498455000},"page":"105-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"special_numbering":"C","title":["Neurofilaments in disease: what do we know?"],"prefix":"10.1016","volume":"61","author":[{"given":"Brian A","family":"Gordon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.conb.2020.02.001_bib0005","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1007\/s00018-004-4268-8","article-title":"Neurofilament proteins in neurodegenerative diseases","volume":"61","author":"Liu","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.conb.2020.02.001_bib0010","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.conb.2020.02.001_bib0015","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018309","article-title":"Neurofilaments and neurofilament proteins in health and disease","volume":"9","author":"Yuan","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.conb.2020.02.001_bib0020","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jns.2005.03.015","article-title":"Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss","volume":"233","author":"Petzold","year":"2005","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.conb.2020.02.001_bib0025","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev.bi.63.070194.002021","article-title":"Intermediate filaments: structure, dynamics, function and disease","volume":"63","author":"Fuchs","year":"1994","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.conb.2020.02.001_bib0030","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1083\/jcb.122.6.1337","article-title":"Neurofilaments are obligate heteropolymers in vivo","volume":"122","author":"Lee","year":"1993","journal-title":"J Cell Biol"},{"key":"10.1016\/j.conb.2020.02.001_bib0035","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1083\/jcb.98.6.2064","article-title":"Monomer-polymer equilibria in the axon: direct measurement of tubulin and actin as polymer and monomer in axoplasm","volume":"98","author":"Morris","year":"1984","journal-title":"J Cell Biol"},{"key":"10.1016\/j.conb.2020.02.001_bib0040","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1073\/pnas.84.10.3472","article-title":"Neurofilament gene expression: a major determinant of axonal caliber","volume":"84","author":"Hoffman","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.conb.2020.02.001_bib0045","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1126\/science.279.5350.514","article-title":"A structural scaffolding of intermediate filaments in health and disease","volume":"279","author":"Fuchs","year":"1998","journal-title":"Science (80-)"},{"key":"10.1016\/j.conb.2020.02.001_bib0050","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/exnr.1997.6654","article-title":"Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments","volume":"148","author":"Zhu","year":"1997","journal-title":"Exp Neurol"},{"key":"10.1016\/j.conb.2020.02.001_bib0055","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1046\/j.1471-4159.1999.0730972.x","article-title":"Disruption of type IV intermediate filament network in mice lacking the neurofilament medium and heavy subunits","volume":"73","author":"Jacomy","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.conb.2020.02.001_bib0060","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/BF00293376","article-title":"Hereditary hypotrophic axonopathy with neurofilament deficiency in a mutant strain of the Japanese quail","volume":"82","author":"Yamasaki","year":"1991","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.conb.2020.02.001_bib0065","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0304-3940(93)90078-Y","article-title":"Reduced diameter and conduction velocity of myelinated fibers in the sciatic nerve of a neurofilament-deficient mutant quail","volume":"153","author":"Sakaguchi","year":"1993","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.conb.2020.02.001_bib0070","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1046\/j.1471-4159.1996.67052013.x","article-title":"Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF","volume":"67","author":"Rosengren","year":"1996","journal-title":"J Neurochem"},{"key":"10.1016\/j.conb.2020.02.001_bib0075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/15368590252917647","article-title":"Monoclonal antibodies selective for low molecular weight neurofilaments","volume":"21","author":"Norgren","year":"2002","journal-title":"Hybrid Hybridomics"},{"key":"10.1016\/j.conb.2020.02.001_bib0080","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0006-8993(03)03219-0","article-title":"Elevated neurofilament levels in neurological diseases","volume":"987","author":"Norgren","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.conb.2020.02.001_bib0085","series-title":"Methods in Molecular Biology","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/7651_2015_206","article-title":"Neurofilament light chain determination from peripheral blood samples","author":"Limberg","year":"2015"},{"key":"10.1016\/j.conb.2020.02.001_bib0090","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1515\/cclm-2015-1195","article-title":"Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa","volume":"54","author":"Kuhle","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.conb.2020.02.001_sbref0095","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1515\/cclm-2019-0015","article-title":"Correlations between serum and CSF pNfH levels in ALS, FTD and controls: a comparison of three analytical approaches","volume":"57","author":"Wilke","year":"2019","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.conb.2020.02.001_bib0100","doi-asserted-by":"crossref","first-page":"e1390","DOI":"10.1212\/WNL.0000000000006318","article-title":"Serum neurofilament light chain in behavioral variant frontotemporal dementia","volume":"91","author":"Steinacker","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.conb.2020.02.001_bib0105","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ana.24552","article-title":"Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis","volume":"79","author":"Weydt","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.conb.2020.02.001_sbref0110","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/nan.12511","article-title":"Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with amyotrophic lateral sclerosis","volume":"45","author":"Gille","year":"2019","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.conb.2020.02.001_bib0115","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1212\/WNL.0000000000003680","article-title":"Blood-based NfL: a biomarker for differential diagnosis of Parkinsonian disorder","volume":"88","author":"Hansson","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.conb.2020.02.001_bib0120","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1212\/WNL.0000000000001642","article-title":"Neurofilament light chain: a prognostic biomarker in amyotrophic lateral sclerosis","volume":"84","author":"Lu","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.conb.2020.02.001_sbref0125","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1474-4422(17)30124-2","article-title":"Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington\u2019s disease: a retrospective cohort analysis","volume":"16","author":"Byrne","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.conb.2020.02.001_bib0130","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1212\/WNL.0000000000003912","article-title":"Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports","volume":"88","author":"Shahim","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.conb.2020.02.001_sbref0135","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2019.1071","article-title":"Association of blood and cerebrospinal fluid tau level and other biomarkers with survival time in sporadic Creutzfeldt-Jakob disease","author":"Staffaroni","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.conb.2020.02.001_sbref0140","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","article-title":"Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer\u2019s disease","volume":"25","author":"Preische","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.conb.2020.02.001_bib0145","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ana.24954","article-title":"Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis","volume":"81","author":"Disanto","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.conb.2020.02.001_bib0150","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1177\/1352458515623365","article-title":"Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity","volume":"22","author":"Kuhle","year":"2016","journal-title":"Mult Scler J"},{"key":"10.1016\/j.conb.2020.02.001_bib0155","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","article-title":"Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease","volume":"74","author":"Mattsson","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.conb.2020.02.001_bib0160","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1212\/WNL.0000000000007767","article-title":"Plasma and CSF neurofilament light: relation to longitudinal neuroimaging and cognitive measures","volume":"93","author":"Mielke","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.conb.2020.02.001_bib0165","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1177\/1352458517715132","article-title":"Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod","volume":"24","author":"Piehl","year":"2018","journal-title":"Mult Scler J"},{"key":"10.1016\/j.conb.2020.02.001_bib0170","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuron.2016.05.018","article-title":"Neurofilament light chain in blood and CSF as marker of disease progression in mouse models and in neurodegenerative diseases","volume":"91","author":"Bacioglu","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.conb.2020.02.001_bib0175","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0022-1759(03)00189-3","article-title":"A specific ELISA for measuring neurofilament heavy chain phosphoforms","volume":"278","author":"Petzold","year":"2003","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.conb.2020.02.001_bib0180","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.bbrc.2005.08.252","article-title":"Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury","volume":"336","author":"Shaw","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.conb.2020.02.001_bib0185","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jneuroim.2010.01.004","article-title":"A highly sensitive electrochemiluminescence immunoassay for the neurofilament heavy chain protein","volume":"220","author":"Kuhle","year":"2010","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.conb.2020.02.001_bib0190","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1212\/WNL.0b013e31821432ff","article-title":"Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis","volume":"76","author":"Kuhle","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.conb.2020.02.001_bib0195","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1471-4159.2011.07224.x","article-title":"Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS","volume":"117","author":"Ganesalingam","year":"2011","journal-title":"J Neurochem"},{"key":"10.1016\/j.conb.2020.02.001_bib0200","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neulet.2018.12.042","article-title":"Neurofilament changes in serum and cerebrospinal fluid after acute ischemic stroke","volume":"698","author":"Pujol-Calder\u00f3n","year":"2019","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.conb.2020.02.001_bib0205","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/acn3.50972","article-title":"Confounding effect of blood volume and body mass index on blood neurofilament light chain levels","volume":"7","author":"Manouchehrinia","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.conb.2020.02.001_bib0210","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2377-13-54","article-title":"Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia","volume":"13","author":"Landqvist Wald\u00f6","year":"2013","journal-title":"BMC Neurol"},{"key":"10.1016\/j.conb.2020.02.001_bib0215","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jalz.2017.12.008","article-title":"Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: evaluation of diagnostic accuracy in the differential diagnosis of prion diseases","volume":"14","author":"Zerr","year":"2018","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.conb.2020.02.001_bib0220","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1001\/jamaneurol.2018.3746","article-title":"Association of cerebrospinal fluid neurofilament light protein levels with cognition in patients with dementia, motor neuron disease, and movement disorders","volume":"76","author":"Olsson","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.conb.2020.02.001_bib0225","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1212\/WNL.52.5.1090","article-title":"Neurofilament protein levels in CSF are increased in dementia","volume":"52","author":"Rosengren","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.conb.2020.02.001_bib0230","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13195-017-0331-1","article-title":"The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias","volume":"10","author":"Abu-Rumeileh","year":"2018","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.conb.2020.02.001_bib0235","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/archneurol.2012.1654","article-title":"Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and\/or Parkinsonian disorders","volume":"69","author":"Hall","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.conb.2020.02.001_bib0240","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ana.24052","article-title":"Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration","volume":"75","author":"Scherling","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.conb.2020.02.001_bib0245","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1212\/WNL.0000000000001015","article-title":"CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival","volume":"83","author":"Skillb\u00e4ck","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.conb.2020.02.001_bib0250","first-page":"12","article-title":"Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients","volume":"87","author":"Steinacker","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.conb.2020.02.001_bib0255","article-title":"CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia","volume":"12","author":"Abu-Rumeileh","year":"2019","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"10.1016\/j.conb.2020.02.001_bib0260","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1212\/WNL.54.10.1960","article-title":"Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD","volume":"54","author":"Sj\u00f6gren","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.conb.2020.02.001_bib0265","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/21678421.2017.1281962","article-title":"Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survival","volume":"18","author":"Skillb\u00e4ck","year":"2017","journal-title":"Amyotroph Lateral Scler Front Degener"},{"key":"10.1016\/j.conb.2020.02.001_bib0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075091","article-title":"Increased neurofilament light chain blood levels in neurodegenerative neurological diseases","volume":"8","author":"Gaiottino","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.conb.2020.02.001_sbref0275","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-31517-z","article-title":"Cerebrospinal fluid concentrations of inflammatory markers in Parkinson\u2019s disease and atypical parkinsonian disorders","volume":"8","author":"Hall","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.conb.2020.02.001_bib0280","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1212\/01.wnl.0000203120.85850.54","article-title":"Axonal damage markers in cerebrospinal fluid are increased in ALS","volume":"66","author":"Brettschneider","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.conb.2020.02.001_bib0285","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000091436","article-title":"The neurofilament heavy chain (NfHSMI35) in the cerebrospinal fluid diagnosis of Alzheimer\u2019s disease","volume":"21","author":"Brettschneider","year":"2006","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.conb.2020.02.001_bib0290","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1002\/mds.21124","article-title":"Neurofilament heavy-chain NfHSMI35 in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes","volume":"21","author":"Brettschneider","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.conb.2020.02.001_bib0295","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1136\/jnnp.64.3.402","article-title":"Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis","volume":"64","author":"Lycke","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.conb.2020.02.001_bib0300","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1212\/01.WNL.0000098880.19793.B6","article-title":"Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS","volume":"61","author":"Malmestr\u00f6m","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.conb.2020.02.001_bib0305","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1212\/WNL.0000000000004683","article-title":"Monitoring disease activity in multiple sclerosis using serum neurofilament light protein","volume":"89","author":"Novakova","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.conb.2020.02.001_sbref0310","doi-asserted-by":"crossref","first-page":"E1007","DOI":"10.1212\/WNL.0000000000007032","article-title":"Blood neurofilament light chain as a biomarker of MS disease activity and treatment response","volume":"92","author":"Kuhle","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.conb.2020.02.001_bib0315","doi-asserted-by":"crossref","first-page":"e598","DOI":"10.1212\/NXI.0000000000000598","article-title":"High serum neurofilament light chain normalizes after hematopoietic stem cell transplantation for MS","volume":"6","author":"Thebault","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"10.1016\/j.conb.2020.02.001_bib0320","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1212\/WNL.0b013e3181a0fe3f","article-title":"Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis","volume":"72","author":"Teunissen","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.conb.2020.02.001_sbref0325","article-title":"Serum neurofilament light chain levels in patients with presymptomatic multiple sclerosis","author":"Bjornevik","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.conb.2020.02.001_bib0330","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1212\/WNL.0000000000003085","article-title":"Neurofilament light chain level is a weak risk factor for the development of MS","volume":"87","author":"Arrambide","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.conb.2020.02.001_bib0335","doi-asserted-by":"crossref","first-page":"E733","DOI":"10.1212\/WNL.0000000000006902","article-title":"Prognostic value of serum neurofilaments in patients with clinically isolated syndromes","volume":"92","author":"Dalla Costa","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.conb.2020.02.001_bib0340","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/ene.13274","article-title":"Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing-remitting multiple sclerosis","volume":"24","author":"H\u00e5kansson","year":"2017","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.conb.2020.02.001_bib0345","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1212\/WNL.0000000000003653","article-title":"Serum neurofilament is associated with progression of brain atrophy and disability in early MS","volume":"88","author":"Kuhle","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.conb.2020.02.001_bib0350","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1177\/1352458518765666","article-title":"Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis","volume":"25","author":"Siller","year":"2019","journal-title":"Mult Scler J"},{"key":"10.1016\/j.conb.2020.02.001_bib0355","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1093\/brain\/awy154","article-title":"Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis","volume":"141","author":"Barro","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.conb.2020.02.001_bib0360","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1111\/ane.12151","article-title":"Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis","volume":"128","author":"Kuhle","year":"2013","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.conb.2020.02.001_bib0365","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/ana.22247","article-title":"Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab","volume":"69","author":"Gunnarsson","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.conb.2020.02.001_bib0370","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1212\/WNL.0000000000001491","article-title":"Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis","volume":"84","author":"Kuhle","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.conb.2020.02.001_bib0375","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.01046","article-title":"A pilot cross-sectional study to investigate the biomarker potential of phosphorylated neurofilament-H and immune mediators of disability in patients with 5 year relapsing-remitting multiple sclerosis","volume":"10","author":"Herrera","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.conb.2020.02.001_bib0380","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1177\/1352458512458010","article-title":"CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome","volume":"19","author":"Khalil","year":"2013","journal-title":"Mult Scler J"},{"key":"10.1016\/j.conb.2020.02.001_bib0385","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00415-009-0131-z","article-title":"CSF neurofilament protein analysis in the differential diagnosis of ALS","volume":"256","author":"Reijn","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.conb.2020.02.001_sbref0390","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1007\/s00415-018-9043-0","article-title":"Significance of CSF NfL and tau in ALS","volume":"265","author":"Schreiber","year":"2018","journal-title":"J Neurol"},{"key":"10.1016\/j.conb.2020.02.001_bib0395","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ana.25276","article-title":"Neurofilament light: a candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversion","volume":"84","author":"Benatar","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.conb.2020.02.001_bib0400","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/jamaneurol.2016.5398","article-title":"Diagnostic and prognostic biomarkers in amyotrophic lateral sclerosis","volume":"74","author":"Gaiani","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.conb.2020.02.001_bib0405","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/acn3.212","article-title":"CSF neurofilament light chain reflects corticospinal tract degeneration in ALS","volume":"2","author":"Menke","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.conb.2020.02.001_bib0410","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1212\/WNL.0000000000004029","article-title":"Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease","volume":"88","author":"Poesen","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.conb.2020.02.001_bib0415","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s00415-017-8730-6","article-title":"CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis","volume":"265","author":"Rossi","year":"2018","journal-title":"J Neurol"},{"key":"10.1016\/j.conb.2020.02.001_sbref0420","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ana.24980","article-title":"Phosphorylated neurofilament heavy chain: a biomarker of survival for C9ORF72-associated amyotrophic lateral sclerosis","volume":"82","author":"Gendron","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.conb.2020.02.001_bib0425","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3109\/21678421.2014.884592","article-title":"Multicentre quality control evaluation of different biomarker candidates for amyotrophic lateral sclerosis","volume":"15","author":"Lehnert","year":"2014","journal-title":"Amyotroph Lateral Scler Front Degener"},{"key":"10.1016\/j.conb.2020.02.001_bib0430","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/j.1471-4159.2009.06386.x","article-title":"Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF-H as a potential ALS biomarker","volume":"111","author":"Boylan","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.conb.2020.02.001_bib0435","doi-asserted-by":"crossref","DOI":"10.1002\/acn3.50890","article-title":"Serum neurofilament heavy chains as early marker of motor neuron degeneration","author":"De Schaepdryver","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.conb.2020.02.001_sbref0440","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/jnnp-2017-316605","article-title":"Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis","volume":"89","author":"De Schaepdryver","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.conb.2020.02.001_bib0445","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3109\/21678421.2012.729596","article-title":"pNfH is a promising biomarker for ALS","volume":"14","author":"Ganesalingam","year":"2013","journal-title":"Amyotroph Lateral Scler Front Degener"},{"key":"10.1016\/j.conb.2020.02.001_bib0450","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/jnnp-2012-303768","article-title":"Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis","volume":"84","author":"Boylan","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.conb.2020.02.001_bib0455","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-Linked FTD and ALS","volume":"72","author":"DeJesus-Hernandez","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.conb.2020.02.001_sbref0460","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2019.1534","article-title":"Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis","author":"Bridel","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.conb.2020.02.001_bib0465","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000099473","article-title":"CSF neurofilaments in frontotemporal dementia compared with early onset Alzheimer\u2019s disease and controls","volume":"23","author":"Pijnenburg","year":"2007","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.conb.2020.02.001_bib0470","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jpsychires.2019.03.019","article-title":"Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia","volume":"113","author":"Al Shweiki","year":"2019","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.conb.2020.02.001_bib0475","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1212\/WNL.0000000000003154","article-title":"Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia","volume":"87","author":"Rohrer","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.conb.2020.02.001_bib0480","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1212\/WNL.0000000000004088","article-title":"CSF sAPP\u03b2, YKL-40, and neurofilament light in frontotemporal lobar degeneration","volume":"89","author":"Alcolea","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.conb.2020.02.001_bib0485","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/jnnp-2018-318704","article-title":"Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis","volume":"90","author":"Verde","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.conb.2020.02.001_sbref0490","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S1474-4422(19)30354-0","article-title":"Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study","volume":"18","author":"van der Ende","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.conb.2020.02.001_bib0495","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/acn3.325","article-title":"Neurofilament light chain: a biomarker for genetic frontotemporal dementia","volume":"3","author":"Meeter","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.conb.2020.02.001_sbref0500","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/jnnp.2006.107326","article-title":"CSF neurofilament proteins in the differential diagnosis of dementia","volume":"78","author":"de Jong","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.conb.2020.02.001_bib0505","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1212\/WNL.0000000000004667","article-title":"Serum neurofilament light in familial Alzheimer disease: a marker of early neurodegeneration","volume":"89","author":"Weston","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.conb.2020.02.001_bib0510","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13195-019-0472-5","article-title":"Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer\u2019s disease","volume":"11","author":"Weston","year":"2019","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.conb.2020.02.001_bib0515","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13195-018-0439-y","article-title":"Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer\u2019s disease","volume":"10","author":"S\u00e1nchez-Valle","year":"2018","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"10.1016\/j.conb.2020.02.001_bib0520","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jalz.2019.01.015","article-title":"Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer\u2019s disease continuum in the BIOMARKAPD study","volume":"15","author":"Lle\u00f3","year":"2019","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.conb.2020.02.001_sbref0525","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2019.0765","article-title":"Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease","author":"Mattsson","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.conb.2020.02.001_bib0530","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.15252\/emmm.201606540","article-title":"Alzheimer\u2019s disease neuroimaging initiative the ADN: cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer\u2019s disease","volume":"8","author":"Mattsson","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.conb.2020.02.001_bib0535","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jamaneurol.2015.3037","article-title":"Association of cerebrospinal fluid neurofilament light concentration with Alzheimer disease progression","volume":"73","author":"Zetterberg","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.conb.2020.02.001_bib0540","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S1474-4422(18)30285-0","article-title":"Plasma and CSF biomarkers for the diagnosis of Alzheimer\u2019s disease in adults with down syndrome: a cross-sectional study","volume":"17","author":"Fortea","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.conb.2020.02.001_bib0545","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jalz.2017.11.015","article-title":"Alzheimer\u2019s disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: A\u03b21\u201342, total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40","volume":"14","author":"Hampel","year":"2018","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.conb.2020.02.001_bib0550","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13195-018-0404-9","article-title":"Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer\u2019s disease","volume":"10","author":"Lewczuk","year":"2018","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.conb.2020.02.001_bib0555","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.neurobiolaging.2011.05.013","article-title":"Serial CSF sampling in Alzheimer\u2019s disease: specific versus non-specific markers","volume":"33","author":"Kester","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.conb.2020.02.001_bib0560","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jalz.2019.01.004","article-title":"Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer\u2019s disease spectrum","volume":"15","author":"Bos","year":"2019","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.conb.2020.02.001_sbref0565","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jamaneurol.2018.3459","article-title":"Association of cerebrospinal fluid neurofilament light protein with risk of mild cognitive impairment among individuals without cognitive impairment","volume":"76","author":"Kern","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.conb.2020.02.001_bib0570","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3233\/JAD-180025","article-title":"Association of plasma neurofilament light chain with neocortical amyloid-\u03b2 load and cognitive performance in cognitively normal elderly participants","volume":"63","author":"Chatterjee","year":"2018","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10.1016\/j.conb.2020.02.001_bib0575","doi-asserted-by":"crossref","first-page":"e518","DOI":"10.1212\/WNL.0000000000004932","article-title":"Plasma neurofilament light chain concentration in the inherited peripheral neuropathies","volume":"90","author":"Sandelius","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.conb.2020.02.001_bib0580","doi-asserted-by":"crossref","DOI":"10.1089\/neu.2018.6341","article-title":"Serum neurofilament light is elevated differentially in older adults with uncomplicated mild traumatic brain injuries","author":"Iverson","year":"2019","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.conb.2020.02.001_bib0585","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jalz.2017.06.2266","article-title":"Amyloid \u03b2 concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis","volume":"13","author":"Ovod","year":"2017","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.conb.2020.02.001_sbref0590","doi-asserted-by":"crossref","first-page":"e1780","DOI":"10.1212\/WNL.0000000000005518","article-title":"Neurofilament light and tau as blood biomarkers for sports-related concussion","volume":"90","author":"Shahim","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.conb.2020.02.001_bib0595","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.neurobiolaging.2006.03.010","article-title":"CSF neurofilament light chain and tau differentiate multiple system atrophy from Parkinson\u2019s disease","volume":"28","author":"Abdo","year":"2007","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.conb.2020.02.001_bib0600","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/mds.870130116","article-title":"Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson\u2019s disease","volume":"13","author":"Holmberg","year":"1998","journal-title":"Mov Disord"},{"key":"10.1016\/j.conb.2020.02.001_bib0605","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jamaneurol.2015.1449","article-title":"Cerebrospinal fluid patterns and the risk of future dementia in early, incident Parkinson disease","volume":"72","author":"B\u00e4ckstr\u00f6m","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.conb.2020.02.001_bib0610","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jocn.2018.09.031","article-title":"Cerebrospinal fluid neurofilament light in suspected sporadic Creutzfeldt-Jakob disease","volume":"60","author":"Kanata","year":"2019","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.conb.2020.02.001_bib0615","doi-asserted-by":"crossref","DOI":"10.1038\/srep38737","article-title":"Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease","volume":"6","author":"Steinacker","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.conb.2020.02.001_bib0620","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3233\/JAD-2010-090649","article-title":"CSF neurofilament proteins levels are elevated in sporadic Creutzfeldt-Jakob disease","volume":"21","author":"Van Eijk","year":"2010","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10.1016\/j.conb.2020.02.001_bib0625","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3171\/2017.10.JNS17352","article-title":"Estimating the global incidence of traumatic brain injury","volume":"130","author":"Dewan","year":"2019","journal-title":"J Neurosurg"},{"key":"10.1016\/j.conb.2020.02.001_bib0630","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1089\/neu.2016.4496","article-title":"Serum neurofilament light protein as a marker for diffuse axonal injury: results from a case series study","volume":"34","author":"Ljungqvist","year":"2017","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.conb.2020.02.001_bib0635","doi-asserted-by":"crossref","DOI":"10.1038\/srep36791","article-title":"Serum neurofilament light protein predicts clinical outcome in traumatic brain injury","volume":"6","author":"Shahim","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.conb.2020.02.001_bib0640","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1089\/neu.2017.5553","article-title":"Longitudinal performance of plasma neurofilament light and tau in professional fighters: the professional fighters brain health study","volume":"35","author":"Bernick","year":"2018","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.conb.2020.02.001_bib0645","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1089\/neu.2015.4295","article-title":"Serum neurofilament light in American football athletes over the course of a season","volume":"33","author":"Oliver","year":"2016","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.conb.2020.02.001_bib0650","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1089\/neu.2007.0488","article-title":"The phosphorylated axonal form of the neurofilament subunit NF-H (pNF-H) as a blood biomarker of traumatic brain injury","volume":"25","author":"Anderson","year":"2008","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.conb.2020.02.001_bib0655","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081249","article-title":"Increased CSF levels of phosphorylated neurofilament heavy protein following bout in amateur boxers","volume":"8","author":"Neselius","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.conb.2020.02.001_bib0660","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1089\/neu.2015.4237","article-title":"The serum phosphorylated neurofilament heavy subunit as a predictive marker for outcome in adult patients after traumatic brain injury","volume":"33","author":"Shibahashi","year":"2016","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.conb.2020.02.001_sbref0665","doi-asserted-by":"crossref","first-page":"e1338","DOI":"10.1212\/WNL.0000000000006282","article-title":"Serum neurofilament light: a biomarker of neuroaxonal injury after ischemic stroke","volume":"91","author":"Tiedt","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.conb.2020.02.001_bib0670","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/ene.13554","article-title":"Serum neurofilament light chain in patients with acute cerebrovascular events","volume":"25","author":"De Marchis","year":"2018","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.conb.2020.02.001_bib0675","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.05.008","article-title":"Serum neurofilament light chain concentration correlates with infarct volume but not prognosis in acute ischemic stroke","volume":"28","author":"Onatsu","year":"2019","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.conb.2020.02.001_bib0680","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jns.2011.01.025","article-title":"Levels of phosphorylated axonal neurofilament subunit H (pNfH) are increased in acute ischemic stroke","volume":"304","author":"Singh","year":"2011","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.conb.2020.02.001_bib0685","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1007\/s11064-011-0553-8","article-title":"Hyperacute detection of neurofilament heavy chain in serum following stroke: a transient sign","volume":"36","author":"Sellner","year":"2011","journal-title":"Neurochem Res"},{"key":"10.1016\/j.conb.2020.02.001_bib0690","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1212\/WNL.0000000000004645","article-title":"Serum neurofilament light is sensitive to active cerebral small vessel disease","volume":"89","author":"Gattringer","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.conb.2020.02.001_bib0695","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.ijcard.2012.12.016","article-title":"Neurofilament light chain as an early and sensitive predictor of long-term neurological outcome in patients after cardiac arrest","volume":"168","author":"Rana","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.conb.2020.02.001_sbref0700","article-title":"Serum neurofilament light chain for prognosis of outcome after cardiac arrest","author":"Moseby-Knappe","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.conb.2020.02.001_bib0705","doi-asserted-by":"crossref","DOI":"10.1186\/cc11244","article-title":"Serial soluble neurofilament heavy chain in plasma as a marker of brain injury after cardiac arrest","volume":"16","author":"Rundgren","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.conb.2020.02.001_bib0710","doi-asserted-by":"crossref","first-page":"e273","DOI":"10.1212\/WNL.0000000000004859","article-title":"AL-108-231 investigators: CSF neurofilament light chain and phosphorylated tau 181 predict disease progression in PSP","volume":"90","author":"Rojas","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.conb.2020.02.001_bib0715","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/acn3.290","article-title":"Plasma neurofilament light chain predicts progression in progressive supranuclear palsy","volume":"3","author":"Rojas","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.conb.2020.02.001_bib0720","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1212\/WNL.0000000000003688","article-title":"Neurofilament as a blood marker for diagnosis and monitoring of primary progressive aphasias","volume":"88","author":"Steinacker","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.conb.2020.02.001_bib0725","doi-asserted-by":"crossref","first-page":"e717","DOI":"10.1212\/WNL.0000000000005005","article-title":"Neurofilament light protein in blood predicts regional atrophy in Huntington disease","volume":"90","author":"Johnson","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.conb.2020.02.001_bib0730","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ebiom.2015.11.036","article-title":"Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: a cross-sectional study","volume":"3","author":"Gissl\u00e9n","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.conb.2020.02.001_sbref0735","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s13365-018-0664-y","article-title":"Neurofilament light chain in blood is negatively associated with neuropsychological performance in HIV-infected adults and declines with initiation of antiretroviral therapy","volume":"24","author":"Anderson","year":"2018","journal-title":"J Neurovirol"},{"key":"10.1016\/j.conb.2020.02.001_bib0740","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1038\/npp.2014.81","article-title":"Elevated concentrations of neurofilament light chain in the cerebrospinal fluid of bipolar disorder patients","volume":"39","author":"Jakobsson","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.conb.2020.02.001_bib0745","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-019-0518-2","article-title":"Plasma neurofilament light chain concentration is increased in anorexia nervosa","volume":"9","author":"Nilsson","year":"2019","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.conb.2020.02.001_bib0750","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/jnnp-2013-307454","article-title":"Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome","volume":"86","author":"Kuhle","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.conb.2020.02.001_sbref0755","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/brain\/awz354","article-title":"Postoperative delirium is associated with increased plasma neurofilament light","volume":"143","author":"Casey","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.conb.2020.02.001_bib0760","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/acn3.779","article-title":"Neurofilament as a potential biomarker for spinal muscular atrophy","volume":"6","author":"Darras","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.conb.2020.02.001_bib0765","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jns.2012.07.043","article-title":"Serum neurofilament concentrations in children with prolonged febrile seizures","volume":"321","author":"Matsushige","year":"2012","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.conb.2020.02.001_bib0770","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1136\/jnnp.2003.017236","article-title":"Axonal degeneration and inflammation in acute optic neuritis","volume":"75","author":"Petzold","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.conb.2020.02.001_bib0775","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/jmri.1076","article-title":"Diffusion tensor imaging: concepts and applications","volume":"13","author":"Le Bihan","year":"2001","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.conb.2020.02.001_bib0780","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neurobiolaging.2018.06.023","article-title":"Neurofilament relates to white matter microstructure in older adults","volume":"70","author":"Moore","year":"2018","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.conb.2020.02.001_bib0785","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11682-017-9732-9","article-title":"Association of longitudinal white matter degeneration and cerebrospinal fluid biomarkers of neurodegeneration, inflammation and Alzheimer\u2019s disease in late-middle-aged adults","volume":"13","author":"Racine","year":"2019","journal-title":"Brain Imaging Behav"},{"key":"10.1016\/j.conb.2020.02.001_bib0790","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2018.10.024","article-title":"Cerebrospinal fluid biomarkers of neurofibrillary tangles and synaptic dysfunction are associated with longitudinal decline in white matter connectivity: a multi-resolution graph analysis","volume":"21","author":"Kim","year":"2019","journal-title":"NeuroImage Clin"}],"container-title":["Current Opinion in Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959438820300398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959438820300398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T12:55:37Z","timestamp":1760705737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959438820300398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":158,"alternative-id":["S0959438820300398"],"URL":"https:\/\/doi.org\/10.1016\/j.conb.2020.02.001","relation":{},"ISSN":["0959-4388"],"issn-type":[{"value":"0959-4388","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurofilaments in disease: what do we know?","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Neurobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conb.2020.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}